ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Bioventus Inc

Bioventus Inc (BVS)

6.58
0.69
(11.71%)
At close: July 11 4:00PM
6.58
0.00
( 0.00% )
After Hours: 4:37PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
6.58
Bid
6.40
Ask
6.65
Volume
506,361
6.02 Day's Range 6.59
2.8214 52 Week Range 7.0399
Market Cap
Previous Close
5.89
Open
6.08
Last Trade
7
@
6.45
Last Trade Time
16:28:47
Financial Volume
$ 3,202,526
VWAP
6.3246
Average Volume (3m)
500,941
Shares Outstanding
79,614,354
Dividend Yield
-
PE Ratio
-3.35
Earnings Per Share (EPS)
-1.96
Revenue
512.35M
Net Profit
-156.23M

About Bioventus Inc

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, in... Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
1970
Bioventus Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker BVS. The last closing price for Bioventus was $5.89. Over the last year, Bioventus shares have traded in a share price range of $ 2.8214 to $ 7.0399.

Bioventus currently has 79,614,354 shares outstanding. The market capitalization of Bioventus is $468.93 million. Bioventus has a price to earnings ratio (PE ratio) of -3.35.

BVS Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.7312.47863247865.856.595.735508766.04606522CS
4-0.19-2.806499261456.776.875.288084935.80236897CS
121.8739.70276008494.717.03993.95009415.79963223CS
261.734.83606557384.887.03993.93071945.59105269CS
523.0284.83146067423.567.03992.82142689234.86218673CS
156-9.69-59.55746773216.2717.640.79993959225.04441409CS
260-8.52-56.423841059615.119.94090.79993733535.75420417CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SNTGSentage Holdings Inc
$ 3.50
(52.17%)
2.46M
AGRIAgriFORCE Growing Systems Ltd
$ 0.102
(24.24%)
35.3M
MAXNMaxeon Solar Technologies Ltd
$ 0.2745
(14.04%)
45.28M
ULYUrgent ly Inc
$ 1.60
(13.48%)
1.38k
ARECAmerican Resources Corporation
$ 0.7623
(10.24%)
3.69k
SISIShineco Inc
$ 1.39
(-34.43%)
115.52k
ASPIASP Isotopes Inc
$ 2.96
(-16.85%)
241.69k
NEXINexImmune Inc
$ 3.32
(-15.52%)
297.25k
LUXHLuxUrban Hotels Inc
$ 0.1575
(-14.17%)
429.79k
LIPOLipella Pharmaceuticals Inc
$ 0.4725
(-11.02%)
269.29k
MAXNMaxeon Solar Technologies Ltd
$ 0.2745
(14.04%)
45.28M
AGRIAgriFORCE Growing Systems Ltd
$ 0.102
(24.24%)
35.3M
KZIAKazia Therapeutics Ltd
$ 1.23
(-0.81%)
6.17M
NVDANVIDIA Corporation
$ 126.42
(-0.77%)
5.95M
ASTIAscent Solar Technologies Inc
$ 0.11
(9.67%)
4.37M

BVS Discussion

View Posts
Monksdream Monksdream 4 weeks ago
BVS under $10
👍️0
tw0122 tw0122 2 months ago
Durolane like it .. older news ..Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

Source: GlobeNewswire Inc.

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract with Aetna™ Medicare Advantage plans. Beginning January 1, 2024, over 3 million Aetna™ Medicare Advantage plan members will have access to DUROLANE to treat knee osteoarthritis (OA) pain. DUROLANE, is a single-injection hyaluronic acid (HA)-based joint-fluid treatment for patients. DUROLANE will be one of two single-injection HA products under contract.
OA involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. Injection treatments of HA-based products, such as DUROLANE, help manage knee OA pain.

“We are pleased DUROLANE is among the preferred options available to both Aetna™ Medicare Advantage members and physicians,” said Anthony Doyle, General Manager, Pain Treatments and Restorative Therapies for Bioventus. “Both now have access to a safe HA product that is proven to provide relief from knee OA pain.”

About Bioventus

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

👍️0
TheFinalCD TheFinalCD 2 months ago
$BVS - Bioventus GAAP EPS of -$0.07 beats by $0.18, revenue of $129.45M beats by $11.07M https://t.co/IGk1Zy2r5X— Seeking Alpha Market News (@MarketCurrents) May 7, 2024
👍️0
Monksdream Monksdream 3 months ago
BVS under $5

👍️0

Your Recent History

Delayed Upgrade Clock